Atlas Trials

Metastatic Skin Squamous Cell Carcinoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Skin Squamous Cell Carcinoma

RecordFirmDate
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725)Fred Hutchinson Cancer Center2026-09-01
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System (NCT07042295)National Cancer Institute (NCI)2026-03-23
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer (NCT05896839)National Cancer Institute (NCI)2024-07-24
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381)Mayo Clinic2022-03-31
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer (NCT04428671)Emory University2020-05-15
Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin (NCT04163952)Rutgers, The State University of New Jersey2020-01-31
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers (NCT03816332)National Cancer Institute (NCI)2019-11-08
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131)M.D. Anderson Cancer Center2017-04-07
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic (NCT02721732)M.D. Anderson Cancer Center2016-08-15
Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma (NCT01198028)M.D. Anderson Cancer Center2011-03-10

Track Metastatic Skin Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.